As of 2025-05-12, the Intrinsic Value of India Glycols Ltd (INDIAGLYCO.NS) is 1,565.01 INR. This INDIAGLYCO.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 1,395.50 INR, the upside of India Glycols Ltd is 12.10%.
The range of the Intrinsic Value is 1,223.47 - 2,105.15 INR
Based on its market price of 1,395.50 INR and our intrinsic valuation, India Glycols Ltd (INDIAGLYCO.NS) is undervalued by 12.10%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 1,223.47 - 2,105.15 | 1,565.01 | 12.1% |
| DCF (Growth 10y) | 1,488.98 - 2,389.08 | 1,843.37 | 32.1% |
| DCF (EBITDA 5y) | 1,411.97 - 2,140.02 | 1,591.22 | 14.0% |
| DCF (EBITDA 10y) | 1,573.33 - 2,363.83 | 1,827.78 | 31.0% |
| Fair Value | 1,688.58 - 1,688.58 | 1,688.58 | 21.00% |
| P/E | 711.90 - 1,286.04 | 971.93 | -30.4% |
| EV/EBITDA | (92.36) - 1,141.26 | 391.27 | -72.0% |
| EPV | (434.57) - (416.96) | (425.76) | -130.5% |
| DDM - Stable | 270.33 - 482.45 | 376.39 | -73.0% |
| DDM - Multi | 1,056.36 - 1,456.74 | 1,224.28 | -12.3% |
| Market Cap (mil) | 43,204.68 |
| Beta | 1.47 |
| Outstanding shares (mil) | 30.96 |
| Enterprise Value (mil) | 58,720.38 |
| Market risk premium | 8.31% |
| Cost of Equity | 19.04% |
| Cost of Debt | 13.73% |
| WACC | 17.25% |